ITASCA, IL--(Marketwire - August 04, 2008) - AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor® system which measures central blood pressures and arterial stiffness non-invasively, today announced record 2008 sales of $6.5m, an increase of 47% on a constant currency basis over the prior period, and in line with expectations. Second half sales in 2008 soared 70% on a constant currency basis over second half sales in 2007.
